Drug dosing optimization in critically ill children under continuous renal replacement therapy: from basic concepts to the bedside model informed precision dosing.

Mehdi Oualha, Michael Thy, Naïm Bouazza, Sihem Benaboud, Agathe Béranger
{"title":"Drug dosing optimization in critically ill children under continuous renal replacement therapy: from basic concepts to the bedside model informed precision dosing.","authors":"Mehdi Oualha, Michael Thy, Naïm Bouazza, Sihem Benaboud, Agathe Béranger","doi":"10.1080/17425255.2024.2422875","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Optimizing drug dosage in critically ill children undergoing Continuous Renal Replacement Therapy (CRRT) is mandatory and challenging, given the many factors impacting pharmacokinetics and pharmacodynamics coupled with the vulnerability of this population.</p><p><strong>Areas covered: </strong>A good understanding of the mechanisms that determine drug elimination via the CRRT technique is useful to avoid prescription pitfalls, however limited by the high between and within subject variability. The developments of population pharmacokinetic and physiologically based pharmacokinetic models derived from in-vivo and in-vitro studies, are challenging, but remain the most appropriate tool to suggest adjusted dosage regimens for every patient, throughout treatment. We searched PubMed using the search string: 'pediatrics OR children' AN 'continuous renal replacement therapy' AND 'pharmacokinetics' AND 'model informed precision dosing' AND, 'physiologically based pharmacokinetics,' AND 'therapeutic drug monitoring' until January 2024, regardless of language or publication status.</p><p><strong>Expert opinion: </strong>Familiarizing the pediatric intensivists with the therapeutic drug monitoring and providing clinicians the individualized prescribing software such as Model Informed Precision Dosing would be a significant step forward. The clinical benefit for patients remains to be demonstrated.</p>","PeriodicalId":94005,"journal":{"name":"Expert opinion on drug metabolism & toxicology","volume":" ","pages":"173-190"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert opinion on drug metabolism & toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17425255.2024.2422875","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Optimizing drug dosage in critically ill children undergoing Continuous Renal Replacement Therapy (CRRT) is mandatory and challenging, given the many factors impacting pharmacokinetics and pharmacodynamics coupled with the vulnerability of this population.

Areas covered: A good understanding of the mechanisms that determine drug elimination via the CRRT technique is useful to avoid prescription pitfalls, however limited by the high between and within subject variability. The developments of population pharmacokinetic and physiologically based pharmacokinetic models derived from in-vivo and in-vitro studies, are challenging, but remain the most appropriate tool to suggest adjusted dosage regimens for every patient, throughout treatment. We searched PubMed using the search string: 'pediatrics OR children' AN 'continuous renal replacement therapy' AND 'pharmacokinetics' AND 'model informed precision dosing' AND, 'physiologically based pharmacokinetics,' AND 'therapeutic drug monitoring' until January 2024, regardless of language or publication status.

Expert opinion: Familiarizing the pediatric intensivists with the therapeutic drug monitoring and providing clinicians the individualized prescribing software such as Model Informed Precision Dosing would be a significant step forward. The clinical benefit for patients remains to be demonstrated.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对接受持续肾脏替代治疗的重症儿童进行药物剂量优化:从基本概念到床边精准用药模型。
简介:由于影响药代动力学和药效学的因素很多,再加上这一人群的脆弱性,对接受持续肾脏替代疗法(CRRT)的重症儿童进行药物剂量优化是必须的,也是具有挑战性的:充分了解决定药物通过 CRRT 技术消除的机制有助于避免处方误区,但受限于受试者之间和受试者内部的高变异性。从体内和体外研究中得出的群体药代动力学和基于生理的药代动力学模型的发展具有挑战性,但仍然是在整个治疗过程中为每位患者建议调整剂量方案的最合适工具。我们使用搜索字符串:"儿科或儿童"、"持续肾脏替代疗法"、"药代动力学"、"基于模型的精确给药"、"基于生理学的药代动力学"、"治疗药物监测 "对PubMed进行了搜索,直至2024年1月,无论语言或出版状态如何:专家意见:让儿科重症监护医生熟悉治疗药物监测,并为临床医生提供个性化处方软件,如 "模型告知精确给药",将是向前迈出的重要一步。对患者的临床益处仍有待证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Transporters and drug secretion into human breast milk. Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review. Evaluating the synergistic use of advanced liver models and AI for the prediction of drug-induced liver injury. A comprehensive review of the efficacy and safety of ertugliflozin. Drug interactions in people with HIV treated with antivirals for other viral illnesses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1